An exciting opportunity has been created for a talented bioinformatician to work on methods for the annotation of drug discovery relevant data. The position is funded by the Open Targets initiative which is a public-private initiative between EMBL-EBI, GlaxoSmithKline, Biogen, Takeda, Celgene, Sanofi and the Sanger Institute to generate and integrate evidence on the validity of biological targets for drug development.
Based in the ChEMBL Team at the European Bioinformatics Institute (EMBL-EBI) the appointee will work with the Open Targets partners to develop pipelines for the identification and integration of information and data to support the role(s) of biological targets in disease into the Open Targets Platform
Reporting to the ChEMBL team leader, you will have excellent attention to detail, strong communication skills and be able to interact with technical experts as well as scientists seeking solutions to their "real world" problems. The specific job responsibilities include: